Motility Medical

Motility Medical is a private U.S. medical device company developing a neuromodulation device intended to restore bowel function in patients with chronic constipation, with an initial focus on neurogenic bowel dysfunction in people with spinal cord injury. The company has described its technology as a non-pharmaceutical device that interfaces with nerves and muscles to facilitate bowel activity. Publicly available information indicates the company began human testing of its prototype in 2020 and has emphasized both spinal cord injury patients and the broader chronic constipation population as target markets. The business appears to be an early-stage healthcare company rather than a traditional drug-development biotech, with limited publicly disclosed pipeline breadth beyond its lead bowel-motility device.